Back to Authors

Scholz, Catherine

A5063754396 | I4210153819

Mayo Clinic

Kura Oncology (United States)

Citations 11

PRELIMINARY RESULTS FROM AN OPEN‐LABEL, PHASE II STUDY OF TIPIFARNIB IN RELAPSED OR REFRACTORY PERIPHERAL T‐CELL LYMPHOMA

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 251-252

10.1002/hon.2438_115